Neighborhood Health Plan changes course, will cover Biogen drug for all patients

Citing new clinical data presented last week by Cambridge drugmaker Biogen, the health insurance plan run by Partners HealthCare says it ’s changing its policy and will now pay for a newly approved drug intended to treat all patients with the rare genetic disease, spinal muscular atrophy. In an email to the Boston Business Journal today, Neighborhood Health Plan Chief Medical Officer Dr. Anton Dodek confirmed that the company deci ded to pay for the drug, called Spinraza, for all patients with SMA. “Based…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news